1. Home
  2. PROF vs SERA Comparison

PROF vs SERA Comparison

Compare PROF & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

N/A

Current Price

$5.76

Market Cap

248.8M

Sector

Health Care

ML Signal

N/A

Logo Sera Prognostics Inc.

SERA

Sera Prognostics Inc.

N/A

Current Price

$1.99

Market Cap

75.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PROF
SERA
Founded
N/A
2008
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Precision Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
248.8M
75.2M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
PROF
SERA
Price
$5.76
$1.99
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
116.8K
22.2K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
25.89
32.32
EPS
N/A
N/A
Revenue
$16,098,000.00
$81,000.00
Revenue This Year
$92.40
$554.81
Revenue Next Year
$64.10
$517.27
P/E Ratio
N/A
N/A
Revenue Growth
50.73
5.19
52 Week Low
$3.92
$1.56
52 Week High
$8.95
$3.95

Technical Indicators

Market Signals
Indicator
PROF
SERA
Relative Strength Index (RSI) 25.89 45.58
Support Level $4.97 $1.88
Resistance Level $6.06 $2.07
Average True Range (ATR) 0.35 0.09
MACD -0.12 -0.01
Stochastic Oscillator 9.42 12.39

Price Performance

Historical Comparison
PROF
SERA

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Share on Social Networks: